Logo image of GANX

GAIN THERAPEUTICS INC (GANX) Stock Earnings & Estimates

NASDAQ:GANX - US36269B1052 - Common Stock

1.97 USD
+0.16 (+8.84%)
Last: 8/22/2025, 8:11:32 PM
2.05 USD
+0.08 (+4.06%)
Pre-Market: 8/25/2025, 8:20:52 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
GANX revenue by date.GANX revenue by date.
160K
433.33%
140K
-12.50%
55.2K
-60.57%

-100.00%
30.197M94.119M
211.68%
238.71M
153.63%
386.2M
61.79%
EBITDA
YoY % growth
GANX ebitda by date.GANX ebitda by date.
-13.81M
-297.98%
-17.72M
-28.31%
-22.17M
-25.11%
N/A
8.58%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
GANX ebit by date.GANX ebit by date.
-13.83M
-297.41%
-17.78M
-28.56%
-22.253M
-25.16%
-22.651M
8.55%
-21.715M
-6.71%
-29.916M
-37.76%
-28.405M
5.05%
-31.364M
-10.42%
-10.267M
67.26%
44.95M
537.80%
162.61M
261.76%
285.42M
75.52%
Operating Margin
GANX operating margin by date.GANX operating margin by date.
-8,643.75%-12,700.00%-40,313.59%N/AN/AN/AN/AN/A-34.00%47.76%68.12%73.90%
EPS
YoY % growth
GANX eps by date.GANX eps by date.
-1.51-1.48
1.99%
-1.78
-20.27%
-0.98
48.31%
-0.63
31.08%
-0.72
-13.69%
-0.71
1.88%
-0.85
-20.40%
-0.36
58.08%
-0.361.69
574.29%
3.90
130.12%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.14
15.00%
-0.16
-43.57%
-0.15
4.38%
-0.17
12.76%
-0.18
-23.53%
-0.19
-21.10%
Revenue
Q2Q % growth
51K51K51K51K
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-5.6M
-25.58%
-6.459M
-93.91%
-8.52M
-73.88%
-9.207M
-83.10%
-9.795M
-74.92%
-10.57M
-63.64%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.19
54.76%
-0.17-0.02-10.66%
Q1 2025
Q2Q % growth
-0.16
27.27%
-0.180.0212.85%
Q4 2024
Q2Q % growth
-0.11
69.44%
-0.190.0841.18%
Q3 2024
Q2Q % growth
-0.17
54.05%
-0.220.0522.48%
Q2 2024
Q2Q % growth
-0.42
32.26%
-0.20-0.22-105.88%
Q1 2024
Q2Q % growth
-0.22
48.84%
-0.300.0826.26%
Q4 2023
Q2Q % growth
-0.36
7.69%
-0.33-0.03-9.44%
Q3 2023
Q2Q % growth
-0.37
2.63%
-0.450.0818.67%
Q2 2023
Q2Q % growth
-0.62
-44.19%
-0.31-0.31-97.67%
Q1 2023
Q2Q % growth
-0.43
-53.57%
-0.40-0.03-7.18%
Q4 2022
Q2Q % growth
-0.39
-21.88%
-0.390.00-1.29%
Q3 2022
Q2Q % growth
-0.38
2.56%
-0.470.0919.01%
Q2 2022
Q2Q % growth
-0.43
-43.33%
-0.32-0.11-34.54%
Q1 2022
Q2Q % growth
-0.28
44.00%
-0.370.0925.30%
Q4 2021
Q2Q % growth
-0.32 -0.500.1835.54%
Q3 2021
Q2Q % growth
-0.39 -0.36-0.03-7.20%
Q2 2021
Q2Q % growth
-0.30 -0.310.013.57%
Q1 2021
Q2Q % growth
-0.50 -0.22-0.28-128.00%
GANX Yearly EPS VS EstimatesGANX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
25.5K-25.5K-100.00%
Q2 2024
Q2Q % growth
408K-408K-100.00%
Q1 2024
Q2Q % growth

-100.00%
30.6K-30.6K-100.00%
Q4 2023
Q2Q % growth
331.5K-331.5K-100.00%
Q3 2023
Q2Q % growth
280.296K-280.296K-100.00%
Q2 2023
Q2Q % growth

-100.00%
1.034M-1.034M-100.00%
Q1 2023
Q2Q % growth
55K
10.00%
55K%
Q4 2022
Q2Q % growth

-100.00%
12.75K-12.75K-100.00%
Q3 2022
Q2Q % growth

-100.00%
58.905K-58.905K-100.00%
Q2 2022
Q2Q % growth
100K
11.11%
27.877K72.123K258.72%
Q1 2022
Q2Q % growth
50K
400.00%
39.78K10.22K25.69%
Q4 2021
Q2Q % growth
40K 52.53K-12.53K-23.85%
Q3 2021
Q2Q % growth
30K 13.597K16.403K120.64%
Q2 2021
Q2Q % growth
90K
800.00%
90K%
Q1 2021
Q2Q % growth
10K 10K%
GANX Yearly Revenue VS EstimatesGANX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2029 2030 2031 2032 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0.53% 18.51%
Revenue0% 0% N/A -100%